US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 7.100
  • +0.030+0.42%
Close Dec 27 16:00 ET
  • 6.750
  • -0.350-4.93%
Post 20:01 ET
335.23MMarket Cap-4.22P/E (TTM)

About Silence Therapeutics Company

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

Company Profile

SymbolSLN
Company NameSilence Therapeutics
Founded1994
CEOMr. Craig A. Tooman
MarketNASDAQ
Employees109
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address72 Hammersmith Road
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW14 8TH
Phone44-20-3457-6900
Websitehttp://www.silence-therapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Craig A. Tooman
  • President, Chief Executive Officer and Director
  • 7.30M
  • Rhonda L. Hellums
  • Chief Financial Officer
  • 2.50M
  • Iain Gladstone Ross
  • Non-Executive Chairman of the Board
  • 402.00K
  • James Lawrence Ede-Golightly
  • Independent Director
  • 182.00K
  • Alistair William Gray
  • Senior Independent Director
  • 193.00K
  • Dr. Michael Harvey Davidson, M.D.
  • Independent Director
  • 178.00K
  • David Jakob Lemus
  • Independent Director
  • 184.00K
  • Dr. Steven Joseph Romano, M.D.
  • Head of Research and Development
  • 1.73M
Heat List
US
Overall
Symbol
Price
% Chg

No Data